Drug Company Will Buy Up to $700 Million in BNB After Coin Hits All-Time High
Windtree Therapeutics plans to purchase up to $700 million in BNB, the fifth-largest cryptocurrency, following its new all-time high. The company, trading on Nasdaq under WINT, seeks to raise $520 million for this investment after initially announcing a $200 million acquisition plan. To facilitate these purchases, Windtree will partner with the crypto exchange Kraken for asset custody. The funds will be raised through a $500 million equity line of credit and a $20 million stock purchase agreement with Build and Build Corp. CEO Jed Latkin emphasized the importance of securing additional funds for acquiring more BNB, which currently holds a $106.9 billion market cap and recently traded around $769. This initiative is part of a trend where publicly traded companies like Windtree are building crypto treasuries to enhance stock value and leverage digital assets. Notably, Windtree's stock rose 162% in the past month despite a 5% drop on the announcement day.
Source đź”—